Home >> WEBINARS >> Developing perspectives on BRCA testing: new horizons for breast cancer

Developing perspectives on BRCA testing: new horizons for breast cancer

Print Friendly, PDF & Email

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Webinar presenters Tabetha Sundin, PhD, HCLD(ABB), MB(ASCP)CM and Leigha Senter-Jamieson, MS, discuss the rationale for BRCA mutation testing in breast cancer, key highlights of the BRCA testing and interpretation process, and reconsidering multi-disciplinary team roles and responsibilities to streamline the testing experience. This on-demand webinar was originally broadcast on March 29, 2018.

CAP TODAY does not endorse any of the products or services named within. US-18810 Last Updated 3/18

x

Check Also

Homologous Recombination Deficiency and BRCA Testing in Ovarian and Breast Cancer

Webinar presenters Dana Chase, MD,  Michelle Shiller, DO, and Tabetha Sundin, PhD discuss the role of BRCA1/2 mutations in homologous recombination deficiency and carcinogenesis, homologous recombination deficiency as a marker of treatment sensitivity, the testing process for homologous recombination deficiency and BRCA mutations, and the role of BRCA testing in ovarian and breast cancer. This on-demand webinar originally broadcast on October 23, 2018.

X